Sahajanand Medical Technologies Ltd.
NSE: SMT | BSE: 545001
₹492.90
₹-41.80
(-7.82%)
As on 09-Nov-2026IST
Market cap
₹5,012 Cr
Revenue (TTM)
₹1,211 Cr
P/E Ratio
76.8
P/B Ratio
6.8
Div. Yield
0 %
Quality Score
2/10
Growth Score
9/10
Valuation Score
1/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹69 Cr
-
ROE
11.5 %
-
ROCE
11.9 %
-
Industry P/E
53.21
-
EV/EBITDA
29.2
-
Debt to Equity
0.4
-
Book Value
₹67.8
-
EPS
₹6.7
-
Face value
1
-
Shares outstanding
101,646,778
10 Years Aggregate
CFO
₹12.38 Cr
EBITDA
₹775.21 Cr
Net Profit
₹83.07 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sahajanand Medical Technologies
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 22.2 | 9.4 | 3.6 | 19.7 | 22.8 | 16.1 | 13.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sahajanand Medical Technologies
|
492.9 | 5,011.7 | 1,210.5 | 69.1 | -- | 11.5 | 76.8 | 6.8 |
| 308.5 | 4,877.4 | 1,149.9 | 115.1 | 13.5 | 12.2 | 42.5 | 5.3 | |
| 537.3 | 17,037.7 | 2,363.5 | 205.5 | 14.6 | 8.1 | 98.2 | 7.6 | |
| 588.4 | 8,786.4 | 2,712.3 | 19.5 | 8.4 | 9.6 | 777.6 | 6.5 | |
| 292.2 | 9,562.8 | 1,620.7 | 186.6 | 16.0 | 12 | 51.3 | 5.9 | |
| 6,007.5 | 6,582.9 | 1,643.9 | 256.3 | 20.8 | 20.4 | 25.7 | 4.7 | |
| 749.7 | 8,131.3 | 1,606.0 | 43.8 | -- | 13 | 185.5 | 8.2 | |
| 264.1 | 11,368.4 | 1,679.4 | 273.6 | -- | 17.9 | 44 | 5.4 | |
| 1,275.2 | 12,970.1 | 1,923.4 | 298.6 | 22.3 | 17.5 | 44.4 | 7.6 | |
| 1,055.9 | 10,200.1 | 1,486.1 | 181.7 | 15.6 | 10.4 | 53.5 | 5.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sahajanand Medical Technologies
Hospital activities
-
Incorporated
2001
-
Chairman
Jose Calle Gordo
-
Managing Director
Bhargav Dhirajlal Kotadia
-
Headquarters
Surat, Gujarat
-
Website
Looking for more details about Sahajanand Medical Technologies Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Sahajanand Medical Technologies
What is the current share price of Sahajanand Medical Technologies Ltd Today?
The share price of Sahajanand Medical Technologies Ltd is ₹492.90 (NSE) and ₹493.05 (BSE) as of 09-Nov-2026 IST. Sahajanand Medical Technologies Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Sahajanand Medical Technologies Ltd?
The P/E ratio of Sahajanand Medical Technologies Ltd is 76.77 times as on 09-Nov-2026, a 44 premium to its peers’ median range of 53.21 times.
The P/B ratio of Sahajanand Medical Technologies Ltd is 6.82 times as on 09-Nov-2026, a 3 premium to its peers’ median range of 6.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
0.00 |
0.00 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of Sahajanand Medical Technologies Ltd?
The 52-week high and low of Sahajanand Medical Technologies Ltd are Rs 565.75 and Rs 346.65 as of 09-Nov-2026.
What is the market cap of Sahajanand Medical Technologies Ltd?
Sahajanand Medical Technologies Ltd has a market capitalisation of ₹ 5,012 Cr as on 09-Nov-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sahajanand Medical Technologies Ltd?
Before investing in Sahajanand Medical Technologies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.